-
Editas Medicine Inc. (EDIT $2.88)
- $2.88 Cap: $241M
- View EDIT Profile
- View Questions on EDIT
Detailed Quote
Questions on this company?
Become a Member
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Editas Medicine Inc. (EDIT $2.88)
- $2.88 Cap: $241M
- View EDIT Profile
- View Questions on EDIT
Q: Hello,
Why Editas stock go up today?
Thanks!
Why Editas stock go up today?
Thanks!
-
Illumina Inc. (ILMN $99.25)
- $99.25 Cap: $15.83B
- View ILMN Profile
- View Questions on ILMN
-
Telo Genomics Corp. (TELO)
- Fwd P/E: -21.9X Cap: $2M
- View TELO Profile
- View Questions on TELO
-
Invitae Corporation (NVTA)
- Cap: $5M
- View NVTA Profile
- View Questions on NVTA
-
Editas Medicine Inc. (EDIT $2.88)
- $2.88 Cap: $241M
- View EDIT Profile
- View Questions on EDIT
-
CRISPR Therapeutics AG (CRSP $56.80)
- $56.80 Cap: $5.09B
- View CRSP Profile
- View Questions on CRSP
-
ARK Genomic Revolution ETF (ARKG $25.27)
- $25.27 Fwd P/E: 20.56X Cap: $889M
- View ARKG Profile
- View Questions on ARKG
Q: The genome space seems to have taken a hit and I'd like to add some to my portfolio. Can you give me 3 to 5 Canadian or US stocks going forward that you believe have the highest potential of gains( I realise this would also be subject to the most risk) for a 5 plus year hold.
Also 3 to 5 stocks from Canada or US that you feel should be held for long term exposure.
Thank you.
Also 3 to 5 stocks from Canada or US that you feel should be held for long term exposure.
Thank you.
-
Editas Medicine Inc. (EDIT $2.88)
- $2.88 Cap: $241M
- View EDIT Profile
- View Questions on EDIT
-
CRISPR Therapeutics AG (CRSP $56.80)
- $56.80 Cap: $5.09B
- View CRSP Profile
- View Questions on CRSP
-
Intellia Therapeutics Inc. (NTLA $11.54)
- $11.54 Cap: $1.25B
- View NTLA Profile
- View Questions on NTLA
Q: Hello,
I took a 1% position, total, in these 3 names about a year ago, as a speculative buy. They have all declined, rather significantly since my initial buy, making all 3 names less than 1% of my total portfolio. I have however noticed some recent relative strength. Would you move on or do you see this area as an interesting speculative buy? To note, I also own a 1.5% position in Illumina. Thanks as always
I took a 1% position, total, in these 3 names about a year ago, as a speculative buy. They have all declined, rather significantly since my initial buy, making all 3 names less than 1% of my total portfolio. I have however noticed some recent relative strength. Would you move on or do you see this area as an interesting speculative buy? To note, I also own a 1.5% position in Illumina. Thanks as always
Insiders
Share Information
SEC Filings
News and Media